<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1834">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05137288</url>
  </required_header>
  <id_info>
    <org_study_id>00013006</org_study_id>
    <nct_id>NCT05137288</nct_id>
  </id_info>
  <brief_title>Intrathecal Atropine Versus Intravenous Ondasetron in Post Operative Nausea Due to Intrathecal Morphine</brief_title>
  <official_title>Intrathecal Atropine Versus Preoperative Intravenous Ondasetron for Prevention of Postoperative Nausea and Vomiting Due to Intrathecal Morphine in Perineal Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare between intrathecal atropine versus preoperative administration of IV ondansetron&#xD;
      in decreasing incidence of post operative nausea and vomiting related to intrathecal opioids&#xD;
      in post operative period in perineal surgery as regard : efficacy and side effects .&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2021</start_date>
  <completion_date type="Anticipated">August 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>frequency of attacks of postoperative nausea and vomiting</measure>
    <time_frame>6-9 months</time_frame>
    <description>Intrathecal atropine versus preoperative intravenous ondasetron for prevention of postoperative nausea and vomiting due to intrathecal morphine</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Perineal Surgery</condition>
  <arm_group>
    <arm_group_label>patients receiving intrathecal atropine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient received intrathecal hyperbaric bupivacaine ( 10 mg ) ( 2 ml 0.5% ) with morphine 250mic and atropine sulphate 100 micwith total volume = 2.5 ml .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>patients receiving preoperative intravenous ondasetron</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient received intrathecal hyperbaric bupivacaine ( 10 mg ) ( 2 ml 0.5% with 0.5 ml normal saline with morphine 250 mic ) with total volume = 2.5 ml with giving 4 mg IV ondansetron before anesthesia ( patients with body weight more than 80 Kg may need additional 4 mg IV ) .</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ondansetron , atropine and bupivacaine</intervention_name>
    <description>Patient received intrathecal hyperbaric bupivacaine ( 10 mg ) ( 2 ml 0.5% ) with morphine 250mic and atropine sulphate 100 micwith total volume = 2.5 ml .&#xD;
Patient received intrathecal hyperbaric bupivacaine ( 10 mg ) ( 2 ml 0.5% with 0.5 ml normal saline with morphine 250 mic ) with total volume = 2.5 ml with giving 4 mg IV ondansetron before anesthesia ( patients with body weight more than 80 Kg may need additional 4 mg IV ) .</description>
    <arm_group_label>patients receiving intrathecal atropine</arm_group_label>
    <arm_group_label>patients receiving preoperative intravenous ondasetron</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between ( 18 - 45 ) years.&#xD;
&#xD;
          -  Body mass index between ( 18.5 - 35 )&#xD;
&#xD;
          -  patients undergoing perineal surgery as anal fissure , piles and rectocele&#xD;
&#xD;
          -  patients receiving bupivacaine ( 20 mg / 4 ml ) as spinal anesthesia&#xD;
&#xD;
          -  Patinets with physical status 1 or 2 according to ASA classification&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient refusal .&#xD;
&#xD;
          -  Any contraindication of neuraxial block as : coagulopathy , skin infection at&#xD;
             injection site or bacteremia , hypovolemia and shock , history of allergy to L.A ,&#xD;
             sever aortic stenosis or mitral stenosis ……… etc&#xD;
&#xD;
          -  Patients with physical status other than 1 and 2 according to ASA classification&#xD;
&#xD;
          -  Those with history of nausea and vomiting , also those who received anti emetic drugs&#xD;
             in last 2 hours of operation .&#xD;
&#xD;
          -  Allergy to any of the drug included in this study .&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>shehab m mohamed, resident</last_name>
    <phone>01147223196</phone>
    <email>shehabmahmoud@med.sohag.edu.eg</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>elhadad a mousa, professor</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sohag University Hospital</name>
      <address>
        <city>Sohag</city>
        <country>Egypt</country>
      </address>
    </facility>
    <contact>
      <last_name>osama r elsherif, professor</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Gybels J, Erdine S, Maeyaert J, Meyerson B, Winkelmüller W, Augustinsson L, Bonezzi C, Brasseur L, DeJongste M, Kupers R, Marchettini P, Muller-Schwefe G, Nitescu P, Plaghki L, Reig E, Spincemaille G, Thomson S, Tronnier V, Van Buyten JP. Neuromodulation of pain. A consensus statement prepared in Brussels 16-18 January 1998 by the following task force of the European Federation of IASP Chapters (EFIC). Eur J Pain. 1998;2(3):203-9.</citation>
    <PMID>15102380</PMID>
  </reference>
  <reference>
    <citation>Baciarello M, Cornini A, Zasa M, Pedrona P, Scrofani G, Venuti FS, Fanelli G. Intrathecal atropine to prevent postoperative nausea and vomiting after Cesarean section: a randomized, controlled trial. Minerva Anestesiol. 2011 Aug;77(8):781-8.</citation>
    <PMID>21730925</PMID>
  </reference>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 13, 2021</study_first_submitted>
  <study_first_submitted_qc>November 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2021</study_first_posted>
  <last_update_submitted>November 28, 2021</last_update_submitted>
  <last_update_submitted_qc>November 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Shehab Mahmoud Mohamed</investigator_full_name>
    <investigator_title>resident doctor at anesthesia and ICU department sohag university hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nausea</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atropine</mesh_term>
    <mesh_term>Ondansetron</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

